Twist Bioscience Corporation TWST Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's change in accrued liabilities?
- Twist Bioscience Corporation (TWST) reported change in accrued liabilities of -$5.78M in Q1 2026.
- How has Twist Bioscience Corporation's change in accrued liabilities changed year-over-year?
- Twist Bioscience Corporation's change in accrued liabilities decreased by 4256.1% year-over-year, from $139K to -$5.78M.
- What is the long-term trend for Twist Bioscience Corporation's change in accrued liabilities?
- Over 2 years (2021 to 2025), Twist Bioscience Corporation's change in accrued liabilities has grown at a 35.9% compound annual growth rate (CAGR), from $3.12M to $5.75M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.